Literature DB >> 2012295

Comparative evaluation of propofol or methohexitone as the sole anaesthetic agent for microlaryngeal surgery.

N Best1, F Traugott.   

Abstract

Propofol or methohexitone was given to the same twenty patients on two separate occasions during total intravenous anaesthesia for microlaryngeal surgery. With propofol the quality of induction was superior. Fewer patients required supplementation. Heart rate and blood pressure were well controlled at levels of 110-120% baseline. There were fewer side-effects during maintenance and recovery. Patients were able to return home earlier. However, apnoea and pain on injection occurred frequently, the latter when injection was made into the dorsum of the hand. With methohexitone, apnoea, abnormal movement, nausea, vomiting, headache, restlessness and confusion were common. Cardiovascular variables were poorly maintained at levels of 170-180% baseline. The results suggest that propofol is suitable as the sole anaesthetic agent in patients undergoing microlaryngeal surgery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012295     DOI: 10.1177/0310057X9101900109

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

Review 2.  Propofol. A pharmacoeconomic appraisal of its use in day case surgery.

Authors:  B Fulton; K L Goa
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

Review 3.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Effect of sevoflurane versus propofol-based anesthesia on the hemodynamic response and recovery characteristics in patients undergoing microlaryngeal surgery.

Authors:  Neerja Bharti; Promila Chari; Parag Kumar
Journal:  Saudi J Anaesth       Date:  2012 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.